470 related articles for article (PubMed ID: 28203093)
1. Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase.
Alakel N; Middeke JM; Schetelig J; Bornhäuser M
Onco Targets Ther; 2017; 10():597-605. PubMed ID: 28203093
[TBL] [Abstract][Full Text] [Related]
2. Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy.
Dinnel J; Moore BL; Skiver BM; Bose P
Core Evid; 2015; 10():23-38. PubMed ID: 25610345
[TBL] [Abstract][Full Text] [Related]
3. Rasburicase for the treatment of tumor lysis in hematological malignancies.
Malaguarnera G; Giordano M; Malaguarnera M
Expert Rev Hematol; 2012 Feb; 5(1):27-38. PubMed ID: 22272702
[TBL] [Abstract][Full Text] [Related]
4. A review of tumour lysis syndrome with targeted therapies and the role of rasburicase.
Bose P; Qubaiah O
J Clin Pharm Ther; 2011 Jun; 36(3):299-326. PubMed ID: 21501203
[TBL] [Abstract][Full Text] [Related]
5. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis.
Lopez-Olivo MA; Pratt G; Palla SL; Salahudeen A
Am J Kidney Dis; 2013 Sep; 62(3):481-92. PubMed ID: 23684124
[TBL] [Abstract][Full Text] [Related]
6. Clarifying the role of rasburicase in tumor lysis syndrome.
Sood AR; Burry LD; Cheng DK
Pharmacotherapy; 2007 Jan; 27(1):111-21. PubMed ID: 17192165
[TBL] [Abstract][Full Text] [Related]
7. Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress.
Matuszkiewicz-Rowinska J; Malyszko J
Kidney Blood Press Res; 2020; 45(5):645-660. PubMed ID: 32998135
[TBL] [Abstract][Full Text] [Related]
8. Rasburicase for the prevention and treatment of hyperuricemia in tumor lysis syndrome.
Kennedy LD; Ajiboye VO
J Oncol Pharm Pract; 2010 Sep; 16(3):205-13. PubMed ID: 19923162
[TBL] [Abstract][Full Text] [Related]
9. Prevention and management of tumor lysis syndrome in adults with malignancy.
Sarno J
J Adv Pract Oncol; 2013 Mar; 4(2):101-6. PubMed ID: 25031988
[TBL] [Abstract][Full Text] [Related]
10. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Baeksgaard L; Sørensen JB
Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
[TBL] [Abstract][Full Text] [Related]
11. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
Cheuk DK; Chiang AK; Chan GC; Ha SY
Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome.
Jeon YW; Kwak DH; Park SS; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):595-603. PubMed ID: 28711571
[TBL] [Abstract][Full Text] [Related]
13. Tumor Lysis Syndrome.
Barbar T; Jaffer Sathick I
Adv Chronic Kidney Dis; 2021 Sep; 28(5):438-446.e1. PubMed ID: 35190110
[TBL] [Abstract][Full Text] [Related]
14. Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase).
Pession A; Melchionda F; Castellini C
Biologics; 2008 Mar; 2(1):129-41. PubMed ID: 19707436
[TBL] [Abstract][Full Text] [Related]
15. Rasburicase in cancer-related hyperuricemia.
Rodriguez M; Campara M; Haaf C
Drugs Today (Barc); 2011 Aug; 47(8):591-603. PubMed ID: 21850282
[TBL] [Abstract][Full Text] [Related]
16. A Case Report of Newly Diagnosed Epithelial Ovarian Carcinoma Presenting with Spontaneous Tumor Lysis Syndrome and Its Successful Management with Rasburicase.
Shukla DK; Gupta D; Aggarwal A; Kumar D
Indian J Med Paediatr Oncol; 2017; 38(3):360-362. PubMed ID: 29200691
[TBL] [Abstract][Full Text] [Related]
17. The management of tumor lysis syndrome.
Rampello E; Fricia T; Malaguarnera M
Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis.
Feng X; Dong K; Pham D; Pence S; Inciardi J; Bhutada NS
J Clin Pharm Ther; 2013 Aug; 38(4):301-8. PubMed ID: 23550846
[TBL] [Abstract][Full Text] [Related]
19. [Acute renal failure in patients with tumour lysis sindrome].
Poskurica M; Petrović D; Poskurica M
Srp Arh Celok Lek; 2016; 144(3-4):232-9. PubMed ID: 27483573
[TBL] [Abstract][Full Text] [Related]
20. Tumor lysis syndrome: a systematic review of case series and case reports.
Firwana BM; Hasan R; Hasan N; Alahdab F; Alnahhas I; Hasan S; Varon J
Postgrad Med; 2012 Mar; 124(2):92-101. PubMed ID: 22437219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]